Lawyers and Settlements Lawyers and Settlements
Home Page >> Hot Issues >> Trasylol

Heart Surgery Drug Trasylol and Kidney/Heart Failure

If you have had heart surgery, you may have been given the drug Trasylol, which has been linked to kidney and heart damage. During heart surgery, specifically cardiopulmonary bypass (CPB) or coronary
Contact a lawyer now about your Trasylol claim


[ESPAÑOL]

Trasylol and Kidney/Heart Failure: Personal Stories and Interviews

Trasylol: "I've Gone Through Hell"

Loretta M. says she is sure she was given Trasylol during her open heart surgeries because her doctor spoke about using blood-regulating drugs during surgery. She had two open heart surgeries and experienced serious side effects after both. Like many people, Loretta is upset that Trasylol was used despite the risks associated with the drug. [MORE: TRASYLOL HELL]

Trasylol: "This Shouldn't Have Happened"

trasylol victimNow that patients are learning about Trasylol more complaints are being aired about the use of the drug. However, patients and their families are still not positive about whether or not they received Trasylol during open heart surgery. [MORE: TRASYLOL SHOULDN'T HAVE HAPPENED]

Trasylol Death Unnecessary

Although Trasylol has been recalled, many people are only now realizing that they or their loved ones may have been given the drug during open heart surgery and may have suffered serious adverse reactions to the drug, including kidney failure. [MORE: TRASYLOL DEATH UNNECESSARY]

Trasylol May Have Caused Advanced Kidney Failure

trasylol caused kidney failureMark L. (not his real name) suffered kidney failure shortly after his open heart surgery. However, he does not know for sure if Trasylol was used. Mark is now trying to determine whether or not doctors gave him Trasylol to stop him from bleeding during surgery. [MORE: TRASYLOL KIDNEY DAMAGE]

Trasylol: “We Need To Know About Those Risks”

Roxanne H (not her real name) says she is not sure why her husband died following his open heart surgery but she says that Trasylol may have played a role in his death. Like many others who lost a loved one unexpectedly following open heart surgery, Roxanne is now trying to determine whether or not her husband was given Trasylol. [MORE: TRASYLOL NEED TO KNOW RISKS]

Trasylol: “It Shouldn’t Have Happened”

Trasylol risksCecilia F says that until she saw the 60 Minutes segment on Trasylol she had no idea what happened to her mother. Even now she is not positive that her mother was given Trasylol, but, "based on what happened, it certainly seems possible," she says. Like countless other patients, Cecilia's mother developed complications immediately after open heart surgery. [MORE: TRASYLOL SHOULDN'T HAVE HAPPENED]

Trasylol: “What the Hell Did They Give These People?”

trasylol hellAlice G. says that in the six years since her mother died, her family has struggled to understand what happened. With the recent news about Trasylol, Alice says she may have a better understanding of why her mother died. Although she is not yet positive her mother was given Trasylol during surgery, Alice says that what her mother went through prior to her death sounds a lot like what other patients have experienced. [MORE: TRASYLOL MOTHER'S DEATH]

Trasylol: “A Horrible Death”

Lonne D. is angry that her husband was given Trasylol during his two open heart surgeries. Like many people, she is only now learning that her loved one's kidney failure and subsequent death were likely caused by Trasylol. Now, Lonne says she wants to sue Bayer for the pain it caused her and her husband. [MORE: TRASYLOL DEATH]

Trasylol: A Child’s Life Changed

trasylol childAnthony Moreno's daughter was born with a challenging birth defect that required multiple complex surgeries to correct. This resilient little girl came through the procedures and seemed to be doing well until things took a turn for the worse. Now he wants to find out if Trasylol from Bayer was the cause. It certainly sounds like it. [MORE: TRASYLOL LIFE CHANGED]

Trasylol: “I was in a coma for three weeks.”

Michael Grosso's troubles date back to 1976, when he was struck by a drunk driver and terribly injured. In addition to a crushed leg, a broken jaw, and other injuries, he sustained several broken ribs that lacerated his aorta. Thirty years later, he's trying to cope with the results of more recent surgery, and especially with the results of receiving Trasylol during that surgery. [MORE: TRASYLOL COMA]

Trasylol: “It’s somebody’s fault, it’s not mine.”

Trasylol victim Roy BishopLike many older workers with long experience, Roy Bishop chose to stay on the job long after he could have retired. That was his plan but Trasylol, Bayer's clotting drug, may have put an end to that. [MORE: TRASYLOL FAULT]


Trasylol: Patients Seeking Medical Records

trasylol patient recordsMichael F. says he is not sure whether or not Trasylol was used during his father's open heart surgery. However, after viewing the 60 Minutes segment on Trasylol, Michael realized that the show described exactly what his father went through. [MORE: TRASYLOL MEDICAL RECORDS]


Trasylol: Did it Cause Kidney Failure?

trasylol did it cause kidney failureKristine S. is not sure whether or not she was given Trasylol during her open heart surgery. What she does know is that ten years ago, she had open heart surgery and almost immediately after she was diagnosed with kidney failure. For the past ten years she has been dealing with problems related to her failing kidneys and will one day require a kidney transplant. [MORE: DID TRASYLOL CAUSE KIDNEY FAILURE?]

Trasylol: “Making Everybody Scared”

trasylol monthly deathsChristine S. says she and her husband watched the 60 Minutes Trasylol article in shock. When the report ended, she says they looked at each other and said, "That sounds like Mother, doesn't it?" [MORE: TRASYLOL FEAR]



Trasylol: A Thousand Deaths a Month

trasylol monthly deathsYou have seen his name before, in various articles about Trasylol, the now-vilified drug that was removed from the active market by Bayer AG on November 5th of last year following a two-year hailstorm of salacious revelations. [MORE: THOUSANDS OF TRASYLOL DEATHS]

Trasylol: “I Thought the Problems Were Just Me”

trasylol likely cause of deathAngela R. (not her real name) admits that she does not know if Trasylol was used during her open heart surgery. What she does know is that prior to her surgery, she was not in end-stage kidney failure, which she developed after the surgery. She also knows that nurses in the hospital repeatedly commented that the medication she was given can be hard on a person's kidneys. [MORE: TRASYLOL PROBLEMS]

Did Trasylol Put Husband on Dialysis?

trasylol dialysis "My husband had a heart transplant in July 2003 and for the last four years, he has had a problem with fluid retention," says Myra H. Now, he is on a dialysis machine�for the rest of his life. "I was told that one of the transplant drugs damaged his kidneys but after reading about Trasylol in the New York Times, I wonder if that drug was the cause." [MORE: TRASYLOL & DIALYSIS?]


Information on Trasylol and Kidney/Heart Failure
Trasylol linked to kidney and heart failureTwo studies have linked Trasylol drug injections to serious complications of kidney failure, deadly heart problems and brain disease. The FDA has issued a Public Health Warning and initiated further research into the drug's benefits and risks.

In one study the Ischemia Research and Education Foundation examined 4,374 heart surgery patients worldwide and found that those on Trasylol doubled their risk of developing kidney failure, and more than doubled their risk of heart failure. Patients also had a 181% increased risk of stroke. Many consumers and health officials blame the drug for patients having to use kidney dialysis and even for patient deaths.

A whistleblower alerted the FDA to problems with Trasylol and the FDA subsequently announced, in September 2006, that Bayer had failed to reveal the results of the study that showed Trasylol was linked to an increased risk of death and stroke.

Bayer claimed they did not disclose the study to the FDA because the results were "preliminary" and then took the unusual action of suspending two employees who were supposedly responsible for hiding the study from the FDA.

Heart Surgery - Unexpected Problems

According to the American Heart Association, each year there are approximately six million cardiovascular heart operations including 666,000 open heart surgeries and over 460,000 bypass surgeries. The in-hospital death rate of these patients is not stated but heart-related deaths account for almost one and a half million deaths each year, more than any other cause.

Many patients do not know if Trasylol was used during their heart surgery but patients who have experienced kidney problems or additional heart problems should seek medical consultation to determine if Trasylol is to blame. If a family member died while undergoing heart surgery, you should also ask questions about the use of Trasylol.

Since its approval in 1993, Trasylol, manufactured by Bayer AG, has been used on more than one million patients worldwide. Sales of Trasylol were $171 million in 2004 and $230 million in 2005 and are expected to exceed $600 million in 2006.

Lysosine analogues, aminocaproic acid and tranexamic acid can be used as safe alternatives to using Trasylol. Trasylol is ten times more expensive than generic lysosine analogues. Studies show that using one of the alternative generic drugs would prevent as many as 11,000 dialysis complications annually, would save $1 billion in dialysis costs, and would reduce the cost of blood controlling drugs by $250 million.

If you have had heart surgery and then experienced kidney failure, stroke or congestive heart failure, your symptoms may have been caused by Trasylol. A lawyer can help evaluate your case.




Read More About Trasylol and Kidney/Heart Failure

Trasylol: Bayer Bracing for Lawsuits

As Bayer AG continues to study the results of the Canadian BART trial on Trasylol, and whether or not those findings may compel the manufacturer to lobby health regulators as to the merits of re-marketing a now-vilified drug, its legal arm prepares for its day in court as lawsuits against Bayer mount. [MORE: TRASYLOL BAYER]

2008 Bringing on More Trasylol Lawsuits

trasylol lawsuitsBayer AG has seen quite a few lawsuits filed against it because of its drug Trasylol. Trasylol is also referred to as a bovine pancreatic trypsin inhibitor. It is used to slow bleeding during complex surgeries in those patients who may be prone to heavy bleeding. Basically what it does is slow down what is called fribrinolysis, which is the process the body uses to breakdown any blood clots. [MORE: TRASYLOL LAWSUITS]

Questions about Trasylol Since 1963

When Bayer AG convenes its annual stockholder's meeting on April 25th in Cologne, the German group Coalition against BAYER Dangers (CBG) will be on hand to introduce countermotions to the proceedings, one of which will focus on the history, and dangers of Trasylol (known as Aprotinin). [MORE: TRASYLOL QUESTIONED SINCE 1963]

FDA Did Not Certify Trasylol as Safe

If there is a lesson that could be taken from the Trasylol tragedy, it might be that drug makers who hide, avoid, or mistakenly withhold important safety data from public, or even medical consumption would face certain censure in some fashion as an inducement not to ever allow such an oversight to happen again. [MORE: TRASYLOL NO REPRISALS]

FDA Did Not Certify Trasylol as Safe

Those who did not know what Trasylol was six months ago are probably aware of what it is now. For those who don't know, it is an anti-bleeding drug used during heart bypass surgery since 1993 that was taken off the market in November 2007 because of a link found between use of the drug and kidney failure in patients who received it. [MORE: TRASYLOL NOT CERTIFIED]

The Tragedy of Trasylol: Did the FDA Stonewall Mangano?

The debacle over the handling of Trasylol and the tragedy of thousands of lives lost during the ensuing delay in getting the blood-clotting drug removed from the market, gets more interesting by the day. [MORE: TRASYLOL STONEWALL]

Bayer Now Facing 68 Trasylol Lawsuits

A number of lawsuits have been filed against Bayer AG for the drug Trasylol that was used in patients undergoing heart bypass surgery from 1993 until it was voluntarily suspended by Bayer in November 2007. Before the drug was taken off of the market, there were 19 lawsuits worldwide claiming that the drug had injured or killed those who were administered it during their surgery. [MORE: BAYER TRASYLOL LAWSUITS]

Trasylol: 10,000 Floridians at Risk

tasylol 10,000 ten thousand florida floridians at riskIt was revealed this week that as many as 10,000 Floridians have either lost their lives, or whose health have been seriously compromised at the hands of Trasylol, the vilified anti-bleeding drug pulled from the market in November of last year. [MORE: 10,000 FLORIDIANS AT RISK FROM TRASYLOL]



 
Trasylol and Kidney/Heart Failure Press Releases
MAY-11-08: The tragedy that is Trasylol and the scores of people who have died at the hands of the expensive anti-bleeding drug reads like the plot line of a bad movie. Only in this case, the villain doesn't get it in the end. At least, not yet. That payback may eventually be found in the courts of law as hundreds of lawsuits move forward. [MORE: TRASYLOL TIMELINE]

trasylol lawsuitsMAY-07-08: Bayer AG is facing a new challenge with Trasylol that doesn't have anything to do with the other 78 lawsuits that the drug company is facing. This lawsuit involves a North Carolina man's claims that he is at a financial loss because Trasylol was used during his 2006 heart surgery. Fortunately, he is not one of the tens of thousands of people who have possibly experienced injury from the anti-bleeding drug. [MORE: TRASYLOL BATTLE]

APR-22-08: The medical doctor Professor Dr. Juergen H. Fischer already gave warnings during the 1980's concerning the dangers of TRASYLOL. However, no action was taken. We interviewed Prof. Fischer about the long career of a sometimes deadly drug. [MORE: TRASYLOL SIDE EFFECTS]

trasylol bayerAPR-17-08: Bayer AG has yet another legal battle to face due to complications that have been allegedly caused by its drug Trasylol. This latest suit, filed by a man's widow in St. Louis federal court, says that her husband died of kidney failure after having open-heart-surgery in December 2005. [MORE: TRASYLOL NEW LAWSUIT]

APR-13-08: While Trasylol maker Bayer AG continues to tread water while crunching the numbers from the aborted Canadian BART study, lawsuits that have emerged from the thousands of deaths allegedly attributed to the anti-bleeding agent have been consolidated. [MORE: TRASYLOL DROPPING THE BALL]

Trasylol BartAPR-08-08: The Trasylol debacle, and the anti-bleeding drug's impact on the lives of cardiac surgery patients, is the stuff of moviedom. One can just imagine the Keystone Cops-like scurrying on the part of expert panels convened at the behest of the US Food and Drug Administration (FDA), which twice reviewed and twice re-asserted the wisdom of keeping Trasylol (aprotinin) on the market in spite of mounting evidence suggesting aprotinin's shortcomings. [MORE: TRASYLOL BART CONNECTION]

trasylol haltedMAR-29-08: On March 27, 2008 Bayer AG said that a new trial on Trasylol had to be halted because the risk of death increased due to excessive bleeding. In addition to this new trial, previous studies have shown that Trasylol has a strong link to kidney failure in patients administered the drug when undergoing heart bypass surgery. [MORE: TRASYLOL TRIAL HALTED]

MAR-27-08: There have been a number of studies conducted on the anti-bleeding drug Trasylol that is used during heart bypass surgeries that suggests that it is responsible for kidney failure in patients after their surgery. In fact, one third of patients are believed to have received it during the procedures. [MORE: TRASYLOL KIDNEY FAILURE]

MAR-22-08: For quite some time, Trasylol has been under fire by the medical community because of the fact that it is estimated the drug has caused approximately 22,000 deaths between being approved by the FDA in 1993 and being voluntarily removed from the market by Bayer, its manufacturer, in November 2007. Ironically, studies conducted as early as 1993 showed that Trasylol has a possible toxic effect on the kidneys. [MORE: TRASYLOL STILL USED?]

trasylol lawsuits filedMAR-06-08: On March 3, 2008 it was revealed by a Florida law firm that the injuries and deaths caused by the drug Trasylol in Florida likely exceed 10,000. These 10,000 have either died or have been severely crippled by the various side effects associated with the drug. These side effects include heart attack, stroke, and renal failure. [MORE: TRASYLOL DEATHS MAY EXCEED 10,000 IN FLORIDA]

FEB-28-08: A statement issued by Bayer AG this week, they allege that two recent studies regarding their drug Trasylol are flawed. But a consumer advocacy group called Public Citizen's Health Research Group, has made statements that they believe the studies conducted on the drug are convincing enough that the drug is a danger to those who receive it. [MORE: TRASYLOL STUDY FLAWED]

FEB-25-08: If the February 17th edition of 60 Minutes on CBS wasn't enough to condemn Trasylol in the eyes of Americans, the publication of two additional studies slamming the safety of Trasylol should convince any remaining doubters regarding the mounting evidence that Trasylol leads to an increase in death and kidney failure. [MORE: MEDIA BASHES TRASYLOL]

FEB-18-08: There are several lawsuits that are being launched. Some are adding up into tens of millions of dollars. This is both for alleged negligence on the part of Bayer AG. Other lawsuits are focusing on the loss of lives due to the use of Trasylol. [MORE: BUILDING TRASYLOL LAWSUITS]

FEB-16-08: Managno was involved in a study of Trasylol, involving 5,065 patients in 17 countries. His study found a link between kidney failure requiring dialysis and increased death in patients given Trasylol. That study was published in January 2006 and in September 2006, was presented to the FDA at a meeting. [MORE: TOO MANY TRASYLOL DEATHS]

trasylol on 60 minutesFEB-16-08: Lawsuits have been filed against Bayer AG on behalf of plaintiffs located all over the United States due to alleged suffering of kidney damage as a result of being prescribed Trasylol, which is a drug used during coronary artery bypass graft surgery to prevent excessive bleeding. [MORE: TRASYLOL ON 60 MINUTES]

NOV-19-07: By the time Bayer AG caved to pressure from regulators and pulled Trasylol from the global marketplace earlier this month, an estimated 4.8 million cardiac patients had received the suspended drug since it was first introduced in 1993. Many of those patients, having experienced kidney failure, stroke or heart problems since receiving Trasylol, known generically as aprotinin, may be unaware that it was the Trasylol that lay at the root of their troubles. [MORE: TRASYLOL WAIT]

NOV-13-07: Two days after announcing that Trasylol was subject to a global recall over concern for continued risk of heart attack, kidney failure and death, Bayer AG quietly posted the final report on the study that got them into so much hot water 18 months ago. [MORE: TRASYLOL KILLS]

NOV-10-07: In the days immediately following the widespread voluntary recall of Trasylol from the world pharmaceutical market, it has become increasingly clear that Bayer AG has taken this action as a precaution, and has no plans to abandon Trasylol entirely save for the potential of damming results from a randomized Canadian study. [MORE: DEATHWATCH CONTINUES]

NOV-05-07: Long under a cloud of suspicion and concern, the reputation of Trasylol was further sullied a few weeks ago when the Ottawa-based clinical trial was abruptly halted after it was found that Trasylol could be linked to a higher risk of death than other drugs. [MORE: TRASYLOL SALES HALTED]


Trasylol in the News:
MAY-2-08: A lawsuit filed in April claims Bayer actively marketed Trasylol despite knowing that it carried greater health risks than cheaper and safer alternatives. [BIZ JOURNAL: TRASYLOL]

MAR-24-08: Americas Watchdog is leading a national investigation for people who may have been exposed to Trasylol. [PR WEB: TRASYLOL]

MAR-03-08: It has been revealed that the death and injury toll now likely exceeds 10,000 Floridians killed or crippled by side effects of Trasylol. [SUN HERALD: TRASYLOL]

FEB-26-08: Two more studies have found that heart surgery patients were more likely to die if given the anti-bleeding drug Trasylol, renewing the claims that the drug is dangerous. [TIMES LEADER: TRASYLOL]

FEB-17-08: In 2006, a study showed widespread death associated with Trasylol, and as it turns out there was concern long before that. [CBS NEWS: TRASYLOL]

AUG-05-07: A number of lawsuits have been filed against Bayer, alleging the drug company hid the risks of Trasylol from physicians and patients. The company also failed to inform the FDA about a study that called into question Trasylol's safety. [TIMES: TRASYLOL]

FEB-13-07: Trasylol, used to prevent excessive bleeding during heart surgery, appears to raise the risk of dying in the five years afterward by nearly 50 percent. [SAUK VALLEY: TRASYLOL DEATH]

FEB-07-07: JAMA study reveals that Aprotinin treatment (Trasylol) resulted in 223 deaths among 1072 patients [20.8% 5-year mortality] and was associated with significantly increased mortality compared with control (128 deaths among 1009 patients [12.7%]. [JAMA: TRASYLOL RISK]


Trasylol Kidney or Heart Failure Lawyer Help

If you have had heart surgery such as cardiopulmonary bypass (CPB) or coronary artery bypass graft (CABG) surgery, you may have been administered Trasylol.

If you have suffered kidney failure, heart problems, or other complications after surgery, please click on the link below to send your complaint to a lawyer who will review your claim at no charge to you.




Posted on Jan-27-06
Updated on May-12-08

Search

Search 10,000 recent
cases and settlements
 
FAQ | TOS | Privacy | Disclaimer | About OLM | Contact OLM | Press | Advertise | Link to OLM | Site Map

© 2001-2008 Online Legal Marketing Ltd. All rights reserved.
Online Legal Marketing Ltd.